Constellation shares to be traded on CREST

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

28 August 2015

Constellation Healthcare Technologies, Inc.

("Constellation" or "the Company")

Constellation shares to be traded on CREST

Constellation Healthcare Technologies, Inc., the US-based healthcare services and technology Company, announces that it has introduced a Depository Interest programme with Capita IRG Trustees Limited ("Capita") to enable its common shares to be traded in CREST.

At the time of Admission of Constellation's Common Shares to trading on AIM on 8 December 2014 (and in respect of the subsequent issue of new Common Shares admitted to AIM on 4 June 2015), restrictions on transfer under United States securities laws required that such shares be held in certificated form for a period of at least 12 months following their respective Admission. As a consequence of The EU Regulation on Central Securities Depositories (CSDR), published on 28 August 2014, it is required that (with effect from 1 September 2015) where transactions in transferable securities take place on a trading venue, such as AIM, the relevant securities should be recorded in book entry form in a Central Securities Depository (CSD), such as CREST irrespective of whether the security is currently eligible for electronic settlement or not and applies to all transactions executed under the Rules of the London Stock Exchange irrespective of whether or not the securities are issued by an EU-incorporated issuer.

In order to meet this requirement Constellation will be introducing a Depository Interest programme with effect from 1 September 2015. Under this programme Capita will issue Depository Interests to qualifying shareholders on a one-for-one basis for each qualifying security in the Company held by that qualifying shareholder. Capita will appear on the register of members of the Company as the shareholder but the beneficial interest and all rights in the relevant common shares will remain with the original shareholder. The benefit of dematerialisation is that the Depository Interest can be held and transferred through CREST, thereby enhancing the liquidity of the Company's securities.

The Depository Interests will be traded on the existing line of stock and as such the Company's ISIN and TIDM will remain unchanged (USU210051004 and CHT respectively).

Further information explaining the process of dematerialising shares into Depository Interests will be available on the Company's website at www.constellationhealthgroup.com.

Enquiries: